Bonus BioGroup Ltd. Logo

Bonus BioGroup Ltd.

Develops cell therapies and tissue products for bone grafts and inflammation repair.

BONS | TA

Overview

Corporate Details

ISIN(s):
IL0004850116
LEI:
Country:
Israel
Address:
Park P.O.B 15143, 31905 Haifa
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Bonus BioGroup Ltd. is a clinical-stage biotechnology company specializing in regenerative medicine. The company develops investigational cell therapy and tissue engineering products to address unmet medical needs related to tissue damage, inflammation, and bone loss. Its pipeline is led by two key candidates: BonoFill, a personalized, viable bone graft engineered from a patient's own cells for orthopedic and maxillofacial applications; and MesenCure, an allogeneic cell therapy designed to target inflammation and promote tissue repair. These therapies are currently being evaluated in clinical trials for safety and efficacy.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-27 11:48
Investor Presentation
Company Presentation- 2025
Hebrew (modern) 9.0 MB
2025-05-27 11:48
Regulatory News Service
Company Presentation- 2025
Russian 43.6 KB
2023-07-11 12:06
Investor Presentation
Company Presentation, July 2023
English 3.4 MB
2023-07-11 12:06
Investor Presentation
Company Presentation, July 2023
Russian 44.7 KB
2022-04-11 16:02
Investor Presentation
Company Presentation
English 8.2 MB
2022-04-11 16:02
Registration Form
Company Presentation
Russian 47.1 KB
2022-04-11 15:01
Investor Presentation
Company Presentation
Hebrew (modern) 11.0 MB
2022-04-11 15:01
Pre-Annual General Meeting Information
Company Presentation
Russian 47.1 KB
2022-01-10 10:52
Regulatory News Service
The company inteds to publish an immediate report, trading will be open after …
Hebrew (modern) 105.1 KB

Automate Your Workflow. Get a real-time feed of all Bonus BioGroup Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bonus BioGroup Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bonus BioGroup Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Optipharm.CO.,LTD Logo
Biotech for animal health and xenotransplantation using genetically engineered pig organs.
South Korea 153710
Organoid-based platforms for drug testing and regenerative therapeutics.
South Korea 476040
Oricon Inc. Logo
Provides entertainment industry data, music charts, web media, and marketing services.
Japan 4800
ORIENTBIO Inc. Logo
Provides animal models & technical services for preclinical R&D to pharma & research institutions.
South Korea 002630
Oryzon Genomics S.A. Logo
Develops epigenetic-based medicines for cancer and central nervous system disorders.
Spain ORY
OSCOTECInc. Logo
A clinical-stage drug discovery company developing innovative medicines for unmet needs.
South Korea 039200
OSE Immunotherapeutics Logo
Develops first-in-class immune therapies for oncology and inflammation, partnering for late-stage.
France OSE
Oxurion NV Logo
Acquires European pharmaceutical subcontractors to build an integrated healthcare services group.
Belgium OXUR
PA Co., Ltd Logo
Offers HR solutions like recruitment media, staffing, and childcare to revitalize local communities.
Japan 4766
PCI Biotech Holding Logo
Biopharma firm evaluating its future after discontinuing its core technology development.
Norway PCIB

Talk to a Data Expert

Have a question? We'll get back to you promptly.